These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2120646)

  • 1. Successful treatment of a persistent cyst, developing after ovarian transposition, with leuprolide acetate.
    Jarrell MA; Brumsted JR
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):927-8. PubMed ID: 2120646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The experimental use of surfagon, a synthetic analog of luliberin, in follicular ovarian cysts].
    Krivosheev OG; Chernykh VIa; Vinogradov VA; Nabatchikova NA; Siutkin EA
    Probl Endokrinol (Mosk); 1989; 35(6):54-8. PubMed ID: 2695918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adenomyosis with long-term GnRH analogues: a case report.
    Grow DR; Filer RB
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):538-9. PubMed ID: 1908069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist (leuprolide acetate) induced ovarian hyperstimulation syndrome in a woman undergoing intermittent hemodialysis.
    Hampton HL; Whitworth NS; Cowan BD
    Fertil Steril; 1991 Feb; 55(2):429-31. PubMed ID: 1899400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian transposition in cervical cancer.
    Anderson B; LaPolla J; Turner D; Chapman G; Buller R
    Gynecol Oncol; 1993 May; 49(2):206-14. PubMed ID: 8504989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonist inhibits estrone sulfatase expression of cystic endometriosis in the ovary.
    Maitoko K; Sasaki H
    Fertil Steril; 2004 Aug; 82(2):322-6. PubMed ID: 15302278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report.
    Camisa C; Sexton C; Friedman C
    J Reprod Med; 1989 Aug; 34(8):543-6. PubMed ID: 2509694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites and pleural effusions associated with endometriosis.
    Yu J; Grimes DA
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):533-4. PubMed ID: 1908068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian response to human menopausal gonadotropin after therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Nader S; Berkowitz AS; Winkel CA
    Am J Obstet Gynecol; 1988 Feb; 158(2):403-4. PubMed ID: 3124624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of the ovaries after radical hysterectomy and ovarian transposition.
    Feeney DD; Moore DH; Look KY; Stehman FB; Sutton GP
    Gynecol Oncol; 1995 Jan; 56(1):3-7. PubMed ID: 7821844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double blind clinical trial of two GnRH analogs for the treatment of cystic ovaries in dairy cows.
    Dinsmore RP; White ME; Guard CL; Jasko DJ; Perdrizet JA; Powers PM; Smith MC
    Cornell Vet; 1987 Jul; 77(3):235-43. PubMed ID: 3119289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pulmonary endometriosis with a long-acting GnRH agonist.
    Seltzer VL; Benjamin F
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):929-31. PubMed ID: 2120647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gonadotropin releasing hormone agonists in ovulation induction.
    Dodson WC
    J Reprod Med; 1989 Jan; 34(1 Suppl):76-80. PubMed ID: 2497247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer.
    Kavanagh JJ; Roberts W; Townsend P; Hewitt S
    J Clin Oncol; 1989 Jan; 7(1):115-8. PubMed ID: 2491882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GnRH-agonists in the therapy of endometriosis].
    Hoffmann G; Spitz J; Behrens R
    Ther Umsch; 1990 Dec; 47(12):937-44. PubMed ID: 2128966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study.
    Lewis M; Baker V; Nezhat C
    Fertil Steril; 2010 Nov; 94(6):e81-2; author reply e83. PubMed ID: 20850721
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
    Qublan HS; Amarin Z; Tahat YA; Smadi AZ; Kilani M
    Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide depot before myomectomy.
    Fribourg S
    Fertil Steril; 1990 Apr; 53(4):754. PubMed ID: 2108064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.